The results showcase a robust financial performance with significant year-on-year (YoY) and quarter-on-quarter (QoQ) growth across key financial metrics. The company’s consolidated revenue for ...
Chief Financial Officer at IKS Health Key Financial Highlights: Quarter ended December 31, 2024 * Revenue at Rs6,572 million (15.9% YoY / + 2.2% QoQ growth) * EBITDA at Rs2,006 million at 30.5% of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback